Price$2.71+0.02 (+0.93%)
01:30 PM07:45 PM
News · 26 weeks79-6%
2025-11-022026-04-26
Mix4290d
- Insider24(57%)
- SEC Filings8(19%)
- Other7(17%)
- Earnings2(5%)
- Leadership1(2%)
Latest news
25 items- SECSEC Form DEFA14A filed by Clover Health Investments Corp.DEFA14A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- SECSEC Form DEF 14A filed by Clover Health Investments Corp.DEF 14A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERSEC Form 4 filed by Priest Brady Patrick4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Priest Brady Patrick4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Soares Karen4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Toy Andrew4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Thornton Joseph Clay4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Reynoso Jamie L.4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Wai Conrad4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 3 filed by new insider Oldakowski Joseph Frank3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Thornton Joseph Clay3/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 3 filed by new insider Thornton Joseph Clay3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- PRClover Health to Report First Quarter 2026 Financial Results on May 6, 2026WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will release its financial results after the market closes on Wednesday, May 6, 2026. The Company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter. First Quarter 2026 Conference Webcast Details: What: Clover Health's First Quarter 2026 Earnings Conference CallWhen: Wednesday, May 6, 2026, at 5:00 p.m. Eastern TimeWebcast: To access the webcast, you may register at https://clover-health-1q26-earnings-call.ope
- INSIDERSEC Form 4 filed by Reynoso Jamie L.4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- PRClover Health Empowers Members to Take Charge of Their Health Data Through HealthEx PartnershipWILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, in partnership with HealthEx, today announced a new collaboration that enables Clover Medicare Advantage (MA) members to securely access and share clinical records and claims data, further advancing patients rights to access and share their own health data, which is central to federal interoperability efforts. Through HealthEx, Clover members can choose to connect their health information to tools like Claude so they can better understand and
- INSIDERSEC Form 4 filed by Priest Brady Patrick4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Reynoso Jamie L.4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Toy Andrew4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Wai Conrad4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Soares Karen4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- PRClover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Peter Kuipers is stepping down as the Chief Financial Officer of the Company, effective March 30, 2026. Mr. Kuipers will remain with the Company in an advisory capacity through April 24, 2026 to support a smooth transition and handoff. Mr. Kuipers and the Company noted that his departure does not reflect any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Board of Directors has
- PRMedTech's Edge: How AI and Remote Diagnostics Drive Scalable ValueIssued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 27, 2026 /CNW/ -- Equity-Insider.com News Commentary – The traditional hospital model is undergoing a massive structural shift. Outpatient clinics and ambulatory services are quickly becoming the primary growth engines for the entire U.S. healthcare sector. In fact, Ernst & Young's 2026 outlook confirms that these accessible, lower-acuity care segments are attracting the heaviest strategic capital allocations as health systems realign their infrastructure[1]. This powerful momentum is accelerating across the medical technology space. Recent data from NVIDIA's 2026 healthcare survey shows that 70% of organizations are now ac
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Clover Health Investments Corp.SCHEDULE 13G/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)
- PRPrimary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF PatientsSAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), and a leading AI-powered physician-enablement platform today released a whitepaper titled "Driving Clinical Excellence in Chronic Disease: Counterpart Assistant's Role in Flu Preventative Care." The analysis examines the role of CA's real-time clinical insights on immunization rates and flu-related acute care utilization within Clover Health's Medicare Advantage (MA) population. Influenza remains a major cause of morbidity among Medicare beneficiaries, with 90% to 95% of flu-re
CLOV FAQ
6 questionsWhat does Clover Health Investments Corp. do?
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.Where does CLOV stock trade?
Clover Health Investments Corp. (CLOV) is listed on NASDAQ.What sector and industry is CLOV in?
Clover Health Investments Corp. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about CLOV?
Clover Health Investments Corp. has had 8 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $600.00 price target on 2024-12-17. Recent price targets range from $250.00 to $600.00.What companies are similar to CLOV?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare CLOV side-by-side with any of them on Quantisnow.How can I track CLOV on Quantisnow?
Quantisnow aggregates Clover Health Investments Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLOV to receive live email and push alerts on every new disclosure.